insights_auto
Miks on NOV tõusnud? 2,42%?
Uurige põhjalikumaltchevron_right
NOV:ETR
Novo Nordisk A/S
34,27 €
arrow_upward
+2,42%(+0,81) 1 p
9. okt, 17:35:55 GMT +2 · EUR
search
Kõik sümbolid
| Sümbol | Hind | Muutus | % muutus |
|---|
insights_autoÜksuse NOV põhistatistika genereerimine…
Ava
33,82 €
Kõrge
34,46 €
Madal
33,76 €
Turu kapit.
128,45 mld
Keskm. maht
181,05 tuh
Maht
0,00
52 näd kõrgeim
54,87 €
52 näd madalaim
30,24 €
Töötajate arv
67 tuh
Ava
33,82 €
Kõrge
34,46 €
Madal
33,76 €
Turu kapit.
128,45 mld
Keskm. maht
181,05 tuh
Maht
0,00
52 näd kõrgeim
54,87 €
52 näd madalaim
30,24 €
Töötajate arv
67 tuh
Uudised
Veebiallikatest ja uudistepartneritelt
The Motley Fool
·
1 päeva eest
Bristol Myers Squibb vs. Novo Nordisk: Which Healthcare Stock Is a Better Buy in 2026?
ad-hoc-news.de
·
1 päeva eest
Novo Nordisk stock gains 3.52 percent for the week to EUR 34.39
Simply Wall Street
·
1 päeva eest
Novo Nordisk (NVO) Stock May Trade Below Fair Value After GLP 1 Expansion Plans
https://www.dars.gov.et/
·
2 päeva eest
Novo Nordisk (NVO) Stock Edges Higher: Shares Trade Near $38.45 - Price Target
Profiil
Novo is a Danish multinational pharmaceutical company. Novo manufactures and markets pharmaceutical products and services, primarily diabetes and obesity medications and devices. The corporation was created in 1989, through a merger of two Danish pharmaceutical companies, which date back to the 1920s.
Novo employs approximately 68,800 people in 80 countries, and markets its products in approximately 170 countries. Novo is controlled by majority shareholder Novo Holdings which holds 28% of its shares and a majority of its voting shares.
Novo is a full member of the European Federation of Pharmaceutical Industries and Associations.
The company was ranked 25th among Fortune's 100 Best Companies to Work For in 2010, and subsequently ranked 72nd in 2014 and 73rd in 2017. In January 2012, Novo was named the most sustainable company in the world by the business magazine Corporate Knights. It is a leader in the FTSE4Good Index, and the only European company in the top ten.
Novo is the largest pharmaceutical company in Denmark. In 2023, Novo's market capitalization exceeded the GDP of Denmark's domestic economy, and it became the highest valued company in Europe. Wikipedia
Teave üksuse Novo Nordisk A/S kohta
TegevjuhtMaziar Mike Doustdar
Töötajad66,7 tuh
Asutatud21. dets 1923
PeakontoridBagsværd, Pealinna piirkond, Taani
Sektor-
Veebisaitnovonordisk.com